SCHEMBL5538682

SCHEMBL5538682

CCn1c(C2(OCCCO)CCN(C(=O)OCc3ccccc3)CC2)nc(C(=O)O)c(O)c1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 2/20 0.40
ENPP2 Q13822 1/20 0.39
ATXN2 Q99700 1/20 0.39
OPRD1 P41143 5/20 0.38
OPRK1 P41145 5/20 0.38
HDAC3 O15379 2/20 0.37
HDAC1 Q13547 2/20 0.37
HDAC2 Q92769 2/20 0.37
HDAC6 Q9UBN7 2/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
SMN1; SMN2 Q16637 3/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
CCR5 P51681 2/20 0.36
ACACB O00763 1/20 0.36
CYP2C19 P33261 1/20 0.35
FNTA P49354 1/20 0.35
FNTB P49356 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5528302 0.95 ENPP2 (0.40) ADORA2BENPP2ATXN2OPRD1OPRK1
SCHEMBL5534487 0.90 ACACB (0.39) ADORA2BENPP2ATXN2OPRD1OPRK1
SCHEMBL5527354 0.86 OPRK1 (0.39) ADORA2BENPP2ATXN2OPRD1OPRK1
SCHEMBL5532804 0.81 HDAC1 (0.43) ADORA2BENPP2ATXN2OPRD1OPRK1
SCHEMBL5534382 0.80 OPRD1 (0.40) ADORA2BENPP2ATXN2OPRD1OPRK1
SCHEMBL5536389 0.78 ENPP2 (0.36) ADORA2BENPP2ATXN2OPRD1OPRK1
SCHEMBL2080734 0.76 ENPP2 (0.42) ADORA2BENPP2ATXN2OPRD1OPRK1
SCHEMBL2081516 0.71 ENPP2 (0.43) ADORA2BENPP2ATXN2OPRD1OPRK1
SCHEMBL1117837 0.71 CTSB (0.36) SMN1; SMN2ADORA2A
SCHEMBL5533578 0.69 HDAC1 (0.40) ADORA2BENPP2ATXN2OPRD1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007143446-A1 SPIRO-CONDENSED HETEROTRICYCLIC COMPOUNDS AS HIV INTEGRASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2007-12-13 WO disclosed